
Yunnan Botanee Bio-Technology Group Co.LTD
SZSE:300957.SZ
72.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||
Net Income
| 494.793 | 756.795 | 1,050.416 | 864.062 | 543.755 | 413.061 | 262.923 | 155.406 |
Depreciation & Amortization
| 189.819 | 137.893 | 92.826 | 58.53 | 13.744 | 11.762 | 7.06 | 5.097 |
Deferred Income Tax
| 0 | -89.331 | -29.282 | -1.861 | -2.942 | -3.45 | -1.151 | 1.06 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -5.997 | -186.085 | -346.654 | 223.996 | -150.567 | 67.587 | -182.509 | 31.195 |
Accounts Receivables
| -310.033 | 0 | -222.64 | -45.098 | -186.55 | -64.846 | -69.252 | 18.151 |
Inventory
| 254.895 | 0 | -214.148 | -221.434 | -51.694 | 55.001 | -146.41 | -63.129 |
Accounts Payables
| 0 | 0 | 119.416 | 490.738 | 90.618 | 80.881 | 34.303 | 75.114 |
Other Working Capital
| 49.141 | -186.085 | -29.282 | -0.211 | -2.942 | -3.45 | -36.099 | 94.324 |
Other Non Cash Items
| 16.251 | -8.833 | -27.143 | 6.132 | 24.095 | 22.513 | 14.722 | 10.745 |
Operating Cash Flow
| 694.865 | 610.439 | 769.446 | 1,152.72 | 431.026 | 514.923 | 102.197 | 202.443 |
Investing Activities: | ||||||||
Investments In Property Plant And Equipment
| -378.385 | -274.275 | -353.421 | -270.684 | -89.453 | -61.011 | -31.559 | -13.617 |
Acquisitions Net
| 0 | -493.499 | -7.475 | -6.5 | 89.455 | 61.016 | 2.835 | 0.005 |
Purchases Of Investments
| -5,049.941 | -4,906.032 | -6,801.134 | -8,621.879 | -760 | -60 | 0 | 0 |
Sales Maturities Of Investments
| 4,340.905 | 5,094.117 | 7,143.533 | 6,340.359 | 763.131 | 60.148 | 0 | 0 |
Other Investing Activites
| 3.488 | 61.634 | 0.011 | 0.226 | -89.453 | -61.011 | 0.001 | 0.005 |
Investing Cash Flow
| -1,083.933 | -518.055 | -18.485 | -2,558.477 | -86.32 | -60.859 | -28.723 | -13.612 |
Financing Activities: | ||||||||
Debt Repayment
| 527.197 | 81.249 | -64.72 | 0 | -14.936 | 0 | -42.98 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 2,905.331 | -1.8 | -0.148 | 0 | 0 |
Common Stock Repurchased
| 0 | -109.838 | 0 | -2,862.44 | 0 | -14.788 | 0 | 0 |
Dividends Paid
| -262.516 | -339.14 | -55.46 | -190.62 | -100.8 | -100.8 | -37.369 | -1.375 |
Other Financing Activities
| -212.208 | -200.58 | -0.784 | 2,835.06 | -5.311 | 12.976 | -4.9 | -49.773 |
Financing Cash Flow
| 52.472 | -458.47 | -319.664 | 2,664.24 | -121.047 | -177.978 | -85.249 | -51.148 |
Other Information: | ||||||||
Effect Of Forex Changes On Cash
| -1.227 | -0.725 | 0.026 | -0.004 | -0 | -0 | -0.001 | -0.001 |
Net Change In Cash
| -337.823 | -366.811 | 431.322 | 1,258.48 | 223.659 | 276.086 | -11.777 | 137.682 |
Cash At End Of Period
| 1,736.059 | 2,073.882 | 2,440.693 | 2,009.371 | 750.891 | 527.232 | 251.146 | 262.923 |